Strategies to inhibit cyst formation in ADPKD

被引:38
作者
Calvet, James P. [1 ]
机构
[1] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66160 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2008年 / 3卷 / 04期
关键词
D O I
10.2215/CJN.05651207
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The many hundreds of cysts that grow and expand and ultimately overwhelm and destroy polycystic kidneys arise from the slow but unrelenting proliferation of tubular epithelial cells, eventually giving rise to very large, thin-walled, fluid-filled structures. The growth of these cystic bodies requires two processes: Cell proliferation and fluid secretion. Cyst epithelial cells seem to have a unique phenotype that could offer opportunities for therapeutic intervention. Current evidence has demonstrated that cAMP drives both abnormal cell proliferation, by stimulating the Ras/mitogen-activated protein kinase (MAPK) pathway, and cyst-filling fluid secretion, by activating the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. Both of these cAMP-mediated processes should be considered in the design of strategies targeted to slow cyst growth and enlargement in autosomal dominant polycystic kidney disease.
引用
收藏
页码:1205 / 1211
页数:7
相关论文
共 58 条
[1]   Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors [J].
Allen, E ;
Piontek, KB ;
Garrett-Mayer, E ;
Garcia-Gonzalez, M ;
Gorelick, KL ;
Germino, GG .
HUMAN MOLECULAR GENETICS, 2006, 15 (01) :11-21
[2]   PKD1 induces p21waf1 and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2 [J].
Bhunia, AK ;
Piontek, K ;
Boletta, A ;
Liu, LJ ;
Qian, F ;
Xu, PN ;
Germino, FJ ;
Germino, GG .
CELL, 2002, 109 (02) :157-168
[3]   Polycystin-1 induces resistance to apoptosis through the phosphatidylinositol 3-kinase/Akt signaling pathway [J].
Boca, Manila ;
Distefano, Gianfranco ;
Qian, Feng ;
Bhunia, Anil K. ;
Germino, Gregory G. ;
Boletta, Alessandra .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (03) :637-647
[4]   Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene [J].
Boulter, C ;
Mulroy, S ;
Webb, S ;
Fleming, S ;
Brindle, K ;
Sandford, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (21) :12174-12179
[5]   Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes [J].
Buscà, R ;
Abbe, P ;
Mantoux, F ;
Aberdam, E ;
Peyssonnaux, C ;
Eychène, A ;
Ortonne, JP ;
Ballotti, R .
EMBO JOURNAL, 2000, 19 (12) :2900-2910
[6]   MEK inhibition holds promise for polycystic kidney disease [J].
Calvet, James P. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (06) :1498-1500
[7]   The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro [J].
Davidow, CJ ;
Maser, RL ;
Rome, LA ;
Calvet, JP ;
Grantham, JJ .
KIDNEY INTERNATIONAL, 1996, 50 (01) :208-218
[8]   Gating of the polycystin ion channel signaling complex in neurons and kidney cells [J].
Delmas, P ;
Nauli, SM ;
Li, XG ;
Coste, B ;
Osorio, N ;
Crest, M ;
Brown, DA ;
Zhou, J .
FASEB JOURNAL, 2004, 18 (02) :740-+
[9]  
ERHARDT P, 1995, MOL CELL BIOL, V15, P5524
[10]   Volume progression in autosomal dominant polycystic kidney disease: The major factor determining clinical outcomes [J].
Grantham, Jared J. ;
Chapman, Arlene B. ;
Torres, Vicente E. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (01) :148-157